Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Κύριοι συγγραφείς: | Church, D, Midgley, R, Kerr, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2012
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
ανά: Midgley, R, κ.ά.
Έκδοση: (2005) -
The emergence of 'omics for the management of colorectal cancer.
ανά: Midgley, R, κ.ά.
Έκδοση: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
ανά: Midgley, R, κ.ά.
Έκδοση: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
ανά: Joao Paulo Solar Vasconcelos, κ.ά.
Έκδοση: (2022-12-01) -
Immunotherapy for colorectal cancer.
ανά: Midgley, R, κ.ά.
Έκδοση: (2003)